Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Recruiting now NCT07059962
Run by Bodyport Inc. · for 21 and older · All sexes
What this study is about
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Who can join (things the study team will check)
✅ You may be able to join if…
- Age 21 years or older
- Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
- Able to stand on two bare feet unassisted
- Receiving automated peritoneal dialysis for the treatment of ESKD
- Followed on the Vantive Sharesource Remote Patient Management Platform
🚫 You may not be able to join if…
- Undergoing or plan to undergo hemodialysis in the next 12 months
- Have a life expectancy of less than 12 months
- Are pregnant or plan to become pregnant during the next 12 months
- Weigh greater than 375 lbs
- Planned kidney transplant within the next 12 months
- Have an implanted neurostimulator system
Where this trial is running
- Desert Cities Dialysis, Victorville, California, United States
- Southeastern Clinical Research Institute, Augusta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
Who to contact
Corey Centen · 415-990-5415 · corey@bodyport.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07059962.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.